Depression remains one of the leading causes of disability worldwide, affecting hundreds of millions of individuals across diverse cultures and socioeconomic backgrounds. While conventional interventions—including selective serotonin reuptake inhibitors, cognitive behavioral therapy, and lifestyle modifications—provide substantial relief for many, a significant percentage of patients experience treatment-resistant depression. For these individuals, standard pharmacological protocols fail to […]